An immunodominant SSX-2–derived epitope recognized by CD4+ T cells in association with HLA-DR-Reference-Cited by-同舟云学术

An immunodominant SSX-2–derived epitope recognized by CD4+ T cells in association with HLA-DR

Published:2004-04-15 Issue:8 Volume:113 Page:1225-1233
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Ayyoub Maha,Hesdorffer Charles S.,Montes Monica,Merlo Andrea,Speiser Daniel,Rimoldi Donata,Cerottini Jean-Charles,Ritter Gerd,Scanlan Matthew,Old Lloyd J.,Valmori Danila

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference41 articles.

1. SSX: A multigene family with several members transcribed in normal testis and human cancer

2. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

3. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma.

4. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Exhausted PD-1+CD39+ Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade;Cancers;2022-07-28

2. Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms;Pharmaceutics;2022-07-11

3. PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells;JCI Insight;2021-01-25

4. Post-translational modifications such as citrullination are excellent targets for cancer therapy;Seminars in Immunology;2020-02

5. Critical testing and parameters for consideration when manufacturing and evaluating tumor–associated antigen-specific T cells;Cytotherapy;2019-03